{
    "paper_id": "7bbc1ea49a5caefdf52953d806743e90d6c8c4fd",
    "metadata": {
        "title": "Subviral Particle as Vaccine and Vaccine Platform",
        "authors": [
            {
                "first": "Ming",
                "middle": [],
                "last": "Tan",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "University of Cincinnati College of Medicine",
                    "location": {
                        "settlement": "Cincinnati",
                        "region": "OH"
                    }
                },
                "email": ""
            },
            {
                "first": "Xi",
                "middle": [],
                "last": "Jiang",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "University of Cincinnati College of Medicine",
                    "location": {
                        "settlement": "Cincinnati",
                        "region": "OH"
                    }
                },
                "email": ""
            }
        ]
    },
    "abstract": [
        {
            "text": "Recombinant subvirual particles retain similar antigenic features of their authentic viral capsids and thus have been applied as nonreplicating subunit vaccines against viral infection and illness. Additionally, the self-assembled, polyvalent subviral particles are excellent platforms to display foreign antigens for immune enhancement for vaccine development. These subviral particle-based vaccines are noninfectious and thus safer than the conventional live attenuated and inactivated vaccines. While several VLP vaccines are available in the markets, numerous others, including dual vaccines against more than one pathogen, are under clinical or preclinical development. This article provides an update of these efforts.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        }
    ],
    "body_text": [
        {
            "text": "Most viruses share common spherical or rod-shaped capsids built by multiple subunits of capsid proteins that encapsulate the viral genome. Through bioengineering technology viral capsid proteins can be produced in vitro, resulting in self-assembled, empty virus-like particles (VLPs) (reviewed in [1, 2] ). In addition, smaller particles with less subunits can be produced for some viruses by expression of portions of the major viral capsid proteins [3] [4] [5] [6] [7] . These artificial subviral particles retain the structures and antigenic properties of their native viruses, including the virus-specific molecular patterns and high density of B-and T-cell epitopes to induce potent innate, humoral, and cellular immune responses, respectively, in animals and humans [1, 2] . Thus, these subviral particles are excellent source of materials for vaccine development against many viruses and their associated diseasess. VLPs are usually made by an eukaryotic expression system, including the baculovirus/insect cells, yeast, and mammalian cells, while the smaller subviral particles and hepatitis B virus (HBV) VLPs can be produced through the E. coli expression system (Table 1) , which is more cost-effective. Sevral subviral particle-based vaccines are currently available in the market, while many others are under clinical or preclinical development.",
            "cite_spans": [
                {
                    "start": 297,
                    "end": 300,
                    "text": "[1,",
                    "ref_id": "BIBREF0"
                },
                {
                    "start": 301,
                    "end": 303,
                    "text": "2]",
                    "ref_id": "BIBREF1"
                },
                {
                    "start": 451,
                    "end": 454,
                    "text": "[3]",
                    "ref_id": "BIBREF2"
                },
                {
                    "start": 455,
                    "end": 458,
                    "text": "[4]",
                    "ref_id": "BIBREF3"
                },
                {
                    "start": 459,
                    "end": 462,
                    "text": "[5]",
                    "ref_id": "BIBREF4"
                },
                {
                    "start": 463,
                    "end": 466,
                    "text": "[6]",
                    "ref_id": "BIBREF5"
                },
                {
                    "start": 467,
                    "end": 470,
                    "text": "[7]",
                    "ref_id": "BIBREF6"
                },
                {
                    "start": 772,
                    "end": 775,
                    "text": "[1,",
                    "ref_id": "BIBREF0"
                },
                {
                    "start": 776,
                    "end": 778,
                    "text": "2]",
                    "ref_id": "BIBREF1"
                }
            ],
            "ref_spans": [
                {
                    "start": 1173,
                    "end": 1182,
                    "text": "(Table 1)",
                    "ref_id": null
                }
            ],
            "section": "Introduction"
        },
        {
            "text": "The self-assembled, polyvalent subviral particles are also excellent platforms for antigen presentation to enhance immunogenicity. Through genetic engineering or chemical conjugation heterologous antigens or peptide epitopes can be inserted or conjugated onto the surface of the subviral particles. The polyvalent presentation of the foreign antigens or epitopes on the subviral particles leads to enhanced immunogenicity, providing an effective approach for novel vaccine development. On the other hand, the immunogenicity of the subviral particle is generally maintained without disrupption by the foreign insertion, and thus the chimeric particles can be used as dual or even multivalant vaccines against two or more pathogens. A number of such chimeric particles have been under preclinical development, pointing to a new direction of highly efficient, low cost vaccines against major infectious diseases.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Introduction"
        },
        {
            "text": "Over 30 different subviral particles (Table 1) , representing at least 21 viral families, have been generated so far through recombinant baculovirus, yeast, mammalian cells and E. coli expression systems. Most of them are VLPs comprising one or more full-length viral structural proteins, while others are smaller subviral particles formed by truncated capsid proteins [3] [4] [5] [6] [7] . The most complex subviral particles are VLPs of the rotavirus, influenza virus and coronavirus that contain up to four structure proteins. The smaller subviral particles include the E2 particles (~23 nm) of the hepatitis E virus (HEV) that are composed of the truncated protruding (P) P1 and P2 domains (~30 kDa) of HEV VP1 [2, 3, 8] and the P particles (~20 nm) of norovirus (NoV) that are formed by 24 copies of the P domain (~34 kDa) of the NoV capsid protein VP1 [4, 6, 9] .",
            "cite_spans": [
                {
                    "start": 369,
                    "end": 372,
                    "text": "[3]",
                    "ref_id": "BIBREF2"
                },
                {
                    "start": 373,
                    "end": 376,
                    "text": "[4]",
                    "ref_id": "BIBREF3"
                },
                {
                    "start": 377,
                    "end": 380,
                    "text": "[5]",
                    "ref_id": "BIBREF4"
                },
                {
                    "start": 381,
                    "end": 384,
                    "text": "[6]",
                    "ref_id": "BIBREF5"
                },
                {
                    "start": 385,
                    "end": 388,
                    "text": "[7]",
                    "ref_id": "BIBREF6"
                },
                {
                    "start": 715,
                    "end": 718,
                    "text": "[2,",
                    "ref_id": "BIBREF1"
                },
                {
                    "start": 719,
                    "end": 721,
                    "text": "3,",
                    "ref_id": "BIBREF2"
                },
                {
                    "start": 722,
                    "end": 724,
                    "text": "8]",
                    "ref_id": "BIBREF7"
                },
                {
                    "start": 858,
                    "end": 861,
                    "text": "[4,",
                    "ref_id": "BIBREF3"
                },
                {
                    "start": 862,
                    "end": 864,
                    "text": "6,",
                    "ref_id": "BIBREF5"
                },
                {
                    "start": 865,
                    "end": 867,
                    "text": "9]",
                    "ref_id": "BIBREF8"
                }
            ],
            "ref_spans": [
                {
                    "start": 37,
                    "end": 46,
                    "text": "(Table 1)",
                    "ref_id": null
                }
            ],
            "section": "Subviral particles as vaccines"
        },
        {
            "text": "Most subviral particles can be easily produced in the laboratory ( Table 1) and several of them have reached the markets as effective vaccines after successfully scaled-up production through Good Manufacturing Practices (GMP). These subviral particles are excellent immunogens inducing strong humoral and cellular immune responses as shown by numerous studies (Table 1 ). Immunization of subviral particle vaccines in different animal species and humans, through various routes, such as intranasal, intramuscular, and intraperitoneal administrations, stimulated high antibody as well as high CD4+ proliferative and cytotoxic T lymphocyte (CTL) responses (Table 1) . These features support the subviral partciels to be highly efficient vaccines against many infectous diseases.",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 67,
                    "end": 75,
                    "text": "Table 1)",
                    "ref_id": null
                },
                {
                    "start": 360,
                    "end": 368,
                    "text": "(Table 1",
                    "ref_id": null
                },
                {
                    "start": 654,
                    "end": 663,
                    "text": "(Table 1)",
                    "ref_id": null
                }
            ],
            "section": "Subviral particles as vaccines"
        },
        {
            "text": "To date five subviral particle-based vaccines are commercially available for human use. The two VLP vaccines against human papillomavirus (HPV) are made by L1, the major capsid protein of HPV16 [10] , through recombinant yeasts (Gardasil\u00ae, Merck & Co., NJ, USA) or baculoviruses in insect cells (Cervarix\u00ae, GlaxoSmithKline, London, UK) [10] [11] [12] [13] . Both vaccines have been proven for prevention of cervical and anogenital infection and diseases associated with HPVs. The other two commercial VLP vaccines against hepatitis B viruses (HBVs), Recombivax HB\u00ae (Merck & Co., NJ, USA) and Engerix-B\u00ae (GlaxoSmithKline, London, UK), are made by the small surface antigen of HBV (HBsAg) through recombinant yeasts (Saccharomyces cerevisiae) [14, 15] . These vaccines have been proven effective worldwide against HBV infection. Most recently, a further subviral particle vaccine against HEVs, the HEV 239/Hecolin\u00ae (Xiamen Innovax Biotech, Xiamen, China) that is made through the E. coli system, has been proven by the Chinese health authorities for human use in China [16] . In addition, there are two other subviral particle vaccines, the Ingelvac CircoFLEX\u00ae (Boehringer Ingelheim, Germany) and Porcilis PCV\u00ae (Intervet International, The Netherlands), that are commcercially available for use in domestic pigs against porcine circovirus infection and diseases [17, 18] . Furthermore, the NoV VLP vaccine has shown significant protection against NoV diarrhea in phase II clinical trials [19] [20] [21] , while many other subviral particle vaccines are under intensive preclinical development (Table 1) .",
            "cite_spans": [
                {
                    "start": 194,
                    "end": 198,
                    "text": "[10]",
                    "ref_id": "BIBREF9"
                },
                {
                    "start": 336,
                    "end": 340,
                    "text": "[10]",
                    "ref_id": "BIBREF9"
                },
                {
                    "start": 341,
                    "end": 345,
                    "text": "[11]",
                    "ref_id": "BIBREF10"
                },
                {
                    "start": 346,
                    "end": 350,
                    "text": "[12]",
                    "ref_id": "BIBREF11"
                },
                {
                    "start": 351,
                    "end": 355,
                    "text": "[13]",
                    "ref_id": "BIBREF12"
                },
                {
                    "start": 741,
                    "end": 745,
                    "text": "[14,",
                    "ref_id": "BIBREF13"
                },
                {
                    "start": 746,
                    "end": 749,
                    "text": "15]",
                    "ref_id": "BIBREF14"
                },
                {
                    "start": 1067,
                    "end": 1071,
                    "text": "[16]",
                    "ref_id": "BIBREF15"
                },
                {
                    "start": 1360,
                    "end": 1364,
                    "text": "[17,",
                    "ref_id": "BIBREF16"
                },
                {
                    "start": 1365,
                    "end": 1368,
                    "text": "18]",
                    "ref_id": "BIBREF17"
                },
                {
                    "start": 1486,
                    "end": 1490,
                    "text": "[19]",
                    "ref_id": null
                },
                {
                    "start": 1491,
                    "end": 1495,
                    "text": "[20]",
                    "ref_id": null
                },
                {
                    "start": 1496,
                    "end": 1500,
                    "text": "[21]",
                    "ref_id": null
                }
            ],
            "ref_spans": [
                {
                    "start": 1591,
                    "end": 1600,
                    "text": "(Table 1)",
                    "ref_id": null
                }
            ],
            "section": "Subviral particles as vaccines"
        },
        {
            "text": "In addition to being vaccines, the subviral particles can also be used as vaccine platforms to present foreign antigens and small peptide epitopes of heterologous pathogens for novel vaccine development. The highly stable structures of most subviral particles tolerate an exogenous insertion, which can be achieved through either recombinant DNA technology or chemical conjugation. The native antigenic properties of the inserted antigens or epitopes usually are preserved on the surface of the chimeric particles, while the immunogenicity of the antigen/epitope is significantly enhanced by the polyvalent nature of the subviral particles functioning as an adjuvant. In addition, the major antigenic determinants of the subviral particle carriers are generally preserved, and thus the resulting chimeric particles can be used as a dual vaccine against the pathogens of the insertion and the carrier.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Subviral particles as vaccine platforms"
        },
        {
            "text": "Numerous chimeric particles with antigen or epitope insertions on the surface have been produced (Table 2 ), in which the foreign antigen is usually inserted into a surface loop of the subviral particles. The capacity of a foreign insertion is subviral particle-dependent, with a maximal insertion of 238 residues (green fluorescence protein, GFP) for the HBV VLP [22] and 159 residues (VP8* antigen of rotavirus) for the P particle of NoV [9] being reported. A selection of proper sites of a subviral particle for insertion of exogenous antigens and/or epitopes is important for generation of stable chimeric particles, the distal end of a flexible surface loops is generally a good choice.",
            "cite_spans": [
                {
                    "start": 364,
                    "end": 368,
                    "text": "[22]",
                    "ref_id": null
                },
                {
                    "start": 440,
                    "end": 443,
                    "text": "[9]",
                    "ref_id": "BIBREF8"
                }
            ],
            "ref_spans": [
                {
                    "start": 97,
                    "end": 105,
                    "text": "(Table 2",
                    "ref_id": "TABREF2"
                }
            ],
            "section": "Subviral particles as vaccine platforms"
        },
        {
            "text": "The HBV VLP has been extensively studied as a vaccine platform for presentation of heterologous antigens and epitopes, with a chimeric VLP vaccines reaching to phase III and other two to phase I human trials. One is the RTS,S/AS01 malaria vaccine (GlaxoSmithKline) that comprises of the C-terminal half (189 residues) of the circumsporozoite protein (CSP) of Plasmodium falciparum on the surface of the HBV VLP (HBsAg) with adjuvant AS01 [23]. This chimeric vaccine is currently under phase III evaluations with high protective efficacy [24] and thus will most likely be the first malaria vaccine ever licensed and the first vaccine with a VLP-displayed antigen. Another VLPbased malaria vaccine is ICC-1132 (Malarivax) that is composed of a HBV VLP (HBcAg) displaying multiple epitopes of the P. falciparum CSP [25, 26] . After testing in rodents and nonhuman primates [25], this vaccine candidate was assessed for safety and immunogenicity by a phase I human trial, which showed malaria-and HBV-specific immune responses [26], supportingg ICC-1132 as a potential dual vaccine. The other HBV VLP-based dual vaccine is the M2e-HBcAg chimera, in which the conserved M2e epitope of influenza A virus M2 protein is linked to the HBV VLP through either recombinant DNA technology [27] or chemical conjugation [28] . After a number of animal experiments showing specific immune reponses against the M2e epitope and HBV, as well as protective immunity against influenza virus infection [28-31], the the first phase I trial was performed in 2008, demonstrating its safety and immunogenicity in humans [32, 33] . These data prove the concept that subviral particle can be a practical strategy of novel vaccine development.",
            "cite_spans": [
                {
                    "start": 812,
                    "end": 816,
                    "text": "[25,",
                    "ref_id": null
                },
                {
                    "start": 817,
                    "end": 820,
                    "text": "26]",
                    "ref_id": null
                },
                {
                    "start": 1305,
                    "end": 1309,
                    "text": "[28]",
                    "ref_id": null
                },
                {
                    "start": 1594,
                    "end": 1598,
                    "text": "[32,",
                    "ref_id": null
                },
                {
                    "start": 1599,
                    "end": 1602,
                    "text": "33]",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "Subviral particles as vaccine platforms"
        },
        {
            "text": "Another well studied subviral partcile platform is the bacteriaphage Q\u03b2 VLPs that have been used to develop vaccines to control smoking addiction, hypertention and allergy. Nicotine was cross-linked to Q\u03b2 VLPs, forming nicotine-Q\u03b2 chimeric particle vaccine. Both phase I and II human trials of smokers showed high nicotine-specific immune responses in vaccinated subjects and revealed significantly increased abstinence rates of smoking [34, 35] . The Q\u03b2 VLP was also used to display the epitopes of angiotensin II (Ang-Q\u03b2) and the chimeric vaccine induced high level of angiotensin II-specific IgG and reduced systolic blood pressure in vaccinated rats [36] . A phase I human trial confirmed the high immunogenicity and safety of the chimeric vaccine [36] . In a separate study, an epitope of allergen Der p1 was covalently coupled to the Q\u03b2 VLPs (Der-P1-Q\u03b2). This vaccine induced high immune response and has been shown to be safe in humans [37] .",
            "cite_spans": [
                {
                    "start": 437,
                    "end": 441,
                    "text": "[34,",
                    "ref_id": null
                },
                {
                    "start": 442,
                    "end": 445,
                    "text": "35]",
                    "ref_id": null
                },
                {
                    "start": 654,
                    "end": 658,
                    "text": "[36]",
                    "ref_id": null
                },
                {
                    "start": 752,
                    "end": 756,
                    "text": "[36]",
                    "ref_id": null
                },
                {
                    "start": 943,
                    "end": 947,
                    "text": "[37]",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "Subviral particles as vaccine platforms"
        },
        {
            "text": "There are many other chimeric subviral particle-based vaccines that are in the preclinical evaluation, including those derived from VLPs of polyomaviruses, cowpea mosaic viruses, flock house virus, and NoVs ( Table 2 ). The P particle of NoV that is formed by 24 copies or 12 dimers of the protruding (P) domain of NoV capsid protein (VP1) is highly stable and immunogenic [38, 39] . Three surface loops are identified on each of the P monomer that tolerate a heterologous insertion of at least 159 residues [9, 40] . Two chimeric P particles, each with the rotavirus surface spike protein VP8* [9] and the conserved M2e epitope of influenza A viruses [41], have been successfully constructed. Both chimeric vaccines revealed strong humoral and cellular immune responses, neutralization and protective efficacies against these viruses in mouse models [9, 38, 41] , supporting the two chimeric particles as dual vaccines against rotavirus and NoV, and influenza virus and NoV, respectively.",
            "cite_spans": [
                {
                    "start": 373,
                    "end": 377,
                    "text": "[38,",
                    "ref_id": null
                },
                {
                    "start": 378,
                    "end": 381,
                    "text": "39]",
                    "ref_id": null
                },
                {
                    "start": 508,
                    "end": 511,
                    "text": "[9,",
                    "ref_id": "BIBREF8"
                },
                {
                    "start": 512,
                    "end": 515,
                    "text": "40]",
                    "ref_id": null
                },
                {
                    "start": 595,
                    "end": 598,
                    "text": "[9]",
                    "ref_id": "BIBREF8"
                },
                {
                    "start": 851,
                    "end": 854,
                    "text": "[9,",
                    "ref_id": "BIBREF8"
                },
                {
                    "start": 855,
                    "end": 858,
                    "text": "38,",
                    "ref_id": null
                },
                {
                    "start": 859,
                    "end": 862,
                    "text": "41]",
                    "ref_id": null
                }
            ],
            "ref_spans": [
                {
                    "start": 209,
                    "end": 216,
                    "text": "Table 2",
                    "ref_id": "TABREF2"
                }
            ],
            "section": "Subviral particles as vaccine platforms"
        },
        {
            "text": "The non-replicating subunit vaccine is an important option against many viral pathogens, particularly those that an in vitro cultivation system remains lacking such as human NoV, and that are too dangerous to culture, such as variola virus and Ebola virus. It is also a choice for future vaccines to avoid the safety concerns of conventional live attenuated or inactivated vaccines, such as a safe vaccine for eradication of poliovirus. The recent reports on the increased risk of intussusception of the two live attenuated rotavirus vaccines to vaccinated children [42-44] is a new example of such concerns that could be prevented by a non-replicating subunit vaccine. However, based on current technology, it seems not possible to produce subviral particles of all known viral pathogens. Thus, the technology of subviral particle-based antigen presentation provides an important strategy for vaccine development against those viral pathogens. As shown in the two tables, many subviral particles are capable antigen carriers. Since the major antigenic determinants of many viral pathogens are known (Table 2) , it would be straightforward for design and producing a new vaccine by taking advantage of this technology.",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 1100,
                    "end": 1109,
                    "text": "(Table 2)",
                    "ref_id": "TABREF2"
                }
            ],
            "section": "Challenges and future directions"
        },
        {
            "text": "The past experience suggests that success of a chimeric vaccine may rely on certain levels of structural and/or chemical compatibility between the carriers and the inserted antigens. There is no simple solution to this technical challenge. If such a problem occurs, attempts of other carrier-antigen combinations are encouraged. In addition, a modification of the carrier vectors by including short flexible peptide adaptors to the two arms of the surface loops is an option. Furthermore, the maximal size of an inserted antigen may vary among different carriers, and therefore, selection of proper carriers for larger antigens is also recommended. Finally, selection of appropriate carrier-antigen combinations should be considered based on the target pathogens and host populations. For example, both NoVs and rotaviruses cause acute gastroenteritis in children, the selection of NoV P particle as carrier to present the rotavirus surface antigens is an ideal combination for a highly effective dual vaccine against the two most important causes of acute gastroenteritis in children.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Challenges and future directions"
        },
        {
            "text": "Subviral particle-based vaccines may not be as immunogenic as those replicating viruses following a natural infection. Thus, development of strategies for a maximal efficacy of the subviral vaccines is important, for which optimization of the vaccine formulations and vaccination regimes may be the key, including increase of vaccine doses and dosages, identification of the best administration routes, and use of appropriate adjuvants. In the case that the antigen-presentation approach is used, rational designs of the vaccines by increasing the copy numbers of the inserted antigens/epitopes on each subviral particle carrier should be considered. In addition, insertion of a universal immunue stimulate elements, such as the T cell epitope, may be considered.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Challenges and future directions"
        },
        {
            "text": "Currently, production of most subviral particles relies on a eukaryotic expression system, such as baculovirus/insect cells, yeasts or mammalian cells. Since bacteria can produce subviral particles at lower cost, attempt to improve the prokaryotic expression system for production of more subviral particles would help to reduce the cost of vaccine delivery in the developing countries. It is worth to point out that several smaller or simpler subviral particles, including the VLP of HBV (HBcAg) [22], the P particles of NoV [4, 6] , the E2 particles of HEV [2, 3, 8] , and the small VLP [7] and the L1 capsomeres [45] of HPV, can be readily produced in E. coli with excellent quality and yields. Since all these viral pathogens are prevalent in the developing countries, further study to develop their subviral particles into cost-effective vaccines and vaccine platform for broad application in the developing world is highly significant. Finally, new concept of vaccine delivery, such edible vaccines produced by transgenic vegetbles containing related subviral particles should be explored. ",
            "cite_spans": [
                {
                    "start": 526,
                    "end": 529,
                    "text": "[4,",
                    "ref_id": "BIBREF3"
                },
                {
                    "start": 530,
                    "end": 532,
                    "text": "6]",
                    "ref_id": "BIBREF5"
                },
                {
                    "start": 559,
                    "end": 562,
                    "text": "[2,",
                    "ref_id": "BIBREF1"
                },
                {
                    "start": 563,
                    "end": 565,
                    "text": "3,",
                    "ref_id": "BIBREF2"
                },
                {
                    "start": 566,
                    "end": 568,
                    "text": "8]",
                    "ref_id": "BIBREF7"
                },
                {
                    "start": 589,
                    "end": 592,
                    "text": "[7]",
                    "ref_id": "BIBREF6"
                }
            ],
            "ref_spans": [],
            "section": "Challenges and future directions"
        },
        {
            "text": "\u25a0 Large numbers of subviral particles from different viral families have been made.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Highlights"
        },
        {
            "text": "\u25a0 Subviral particles are highly immunogenic and thus excellent vaccine candidates.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Highlights"
        },
        {
            "text": "\u25a0 Subviral particles are noninfectious and safer vaccine than the conventional ones.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Highlights"
        },
        {
            "text": "\u25a0 Subviral particles are capable platforms for foreign antigen presentation.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Highlights"
        },
        {
            "text": "\u25a0 Several subviral particle-based vaccines are commercially available for human use. Table 1 Some known subviral particles that have been studied as vaccines or immunogens.",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 85,
                    "end": 92,
                    "text": "Table 1",
                    "ref_id": null
                }
            ],
            "section": "Highlights"
        },
        {
            "text": "Production system Immune responses in lab animals (mice) Some subviral particle platforms for display of heterologous antigens and epitopes for vaccine development. ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Virus Family Virus species Subviral particle"
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "Viral nanoparticles and virus-like particles: platforms for contemporary vaccine design",
            "authors": [
                {
                    "first": "E",
                    "middle": [
                        "M"
                    ],
                    "last": "Plummer",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Manchester",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Wiley Interdiscip Rev Nanomed Nanobiotechnol",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "This review article summarizes the long journey of the three commcerial subviral particle vaccines from bench to patients. The physical properties and structural features of the three VLP vaccine are analyzed. The authors also summarize how the crucial quality attributes of VLP-based human vaccines against diseases were assessed, controlled, and improved during bioprocessing through an array of structural and functional analyses",
            "authors": [
                {
                    "first": "*",
                    "middle": [
                        "*"
                    ],
                    "last": "Zhao",
                    "suffix": ""
                },
                {
                    "first": "Q",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Yu",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Xia",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Modis",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Trends Biotechnol",
            "volume": "31",
            "issn": "",
            "pages": "654--663",
            "other_ids": {}
        },
        "BIBREF2": {
            "ref_id": "b2",
            "title": "A bacterially expressed particulate hepatitis E vaccine: antigenicity, immunogenicity and protectivity on primates",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "W"
                    ],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "M"
                    ],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "H"
                    ],
                    "last": "Ou",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "Y"
                    ],
                    "last": "Huang",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [
                        "Q"
                    ],
                    "last": "He",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "X"
                    ],
                    "last": "Ge",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "L"
                    ],
                    "last": "Xian",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "Q"
                    ],
                    "last": "Pang",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "H"
                    ],
                    "last": "Ng",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Vaccine",
            "volume": "23",
            "issn": "",
            "pages": "2893--2901",
            "other_ids": {}
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "Noroviral P particle: Structure, function and applications in virus-host interaction",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Tan",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Fang",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Chachiyo",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Xia",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Huang",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Fang",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Jiang",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Jiang",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Virology",
            "volume": "382",
            "issn": "",
            "pages": "115--123",
            "other_ids": {}
        },
        "BIBREF4": {
            "ref_id": "b4",
            "title": "Terminal modifications of norovirus P domain resulted in a new type of subviral particles, the small P particles",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Tan",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "A"
                    ],
                    "last": "Fang",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Xia",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Chachiyo",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Jiang",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Jiang",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Virology",
            "volume": "410",
            "issn": "",
            "pages": "345--352",
            "other_ids": {}
        },
        "BIBREF5": {
            "ref_id": "b5",
            "title": "The p domain of norovirus capsid protein forms a subviral particle that binds to histo-blood group antigen receptors",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Tan",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Jiang",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Journal of Virology",
            "volume": "79",
            "issn": "",
            "pages": "14017--14030",
            "other_ids": {}
        },
        "BIBREF6": {
            "ref_id": "b6",
            "title": "Structure of small virus-like particles assembled from the L1 protein of human papillomavirus 16",
            "authors": [
                {
                    "first": "X",
                    "middle": [
                        "S"
                    ],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "L"
                    ],
                    "last": "Garcea",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [],
                    "last": "Goldberg",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Casini",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "C"
                    ],
                    "last": "Harrison",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "Mol Cell",
            "volume": "5",
            "issn": "",
            "pages": "557--567",
            "other_ids": {}
        },
        "BIBREF7": {
            "ref_id": "b7",
            "title": "Hepatitis E virus capsid protein assembles in 4M urea in the presence of salts",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Yang",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Pan",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Wei",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Gu",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Du",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Xia",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Protein Sci",
            "volume": "22",
            "issn": "",
            "pages": "314--326",
            "other_ids": {}
        },
        "BIBREF8": {
            "ref_id": "b8",
            "title": "Norovirus P particle, a novel platform for vaccine development and antibody production",
            "authors": [
                {
                    "first": "*",
                    "middle": [],
                    "last": "Tan",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Huang",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Xia",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Fang",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "A"
                    ],
                    "last": "Zhong",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Mcneal",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Wei",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Jiang",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Jiang",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "J Virol",
            "volume": "85",
            "issn": "",
            "pages": "753--764",
            "other_ids": {}
        },
        "BIBREF9": {
            "ref_id": "b9",
            "title": "Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Kirnbauer",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Booy",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Cheng",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "R"
                    ],
                    "last": "Lowy",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "T"
                    ],
                    "last": "Schiller",
                    "suffix": ""
                }
            ],
            "year": 1992,
            "venue": "Proc Natl Acad Sci U S A",
            "volume": "89",
            "issn": "",
            "pages": "12180--12184",
            "other_ids": {}
        },
        "BIBREF10": {
            "ref_id": "b10",
            "title": "Vaccination with multimeric L2 fusion protein and L1 VLP or capsomeres to broaden protection against HPV infection",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Jagu",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Kwak",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "L"
                    ],
                    "last": "Garcea",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "B"
                    ],
                    "last": "Roden",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Vaccine",
            "volume": "28",
            "issn": "",
            "pages": "4478--4486",
            "other_ids": {}
        },
        "BIBREF11": {
            "ref_id": "b11",
            "title": "Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial",
            "authors": [
                {
                    "first": "D",
                    "middle": [
                        "M"
                    ],
                    "last": "Harper",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "L"
                    ],
                    "last": "Franco",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Wheeler",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "G"
                    ],
                    "last": "Ferris",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Jenkins",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Schuind",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Zahaf",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Innis",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Naud",
                    "suffix": ""
                },
                {
                    "first": "De",
                    "middle": [],
                    "last": "Carvalho",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [
                        "S"
                    ],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Lancet",
            "volume": "364",
            "issn": "",
            "pages": "1757--1765",
            "other_ids": {}
        },
        "BIBREF12": {
            "ref_id": "b12",
            "title": "Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial",
            "authors": [
                {
                    "first": "L",
                    "middle": [
                        "L"
                    ],
                    "last": "Villa",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "L"
                    ],
                    "last": "Costa",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "A"
                    ],
                    "last": "Petta",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "P"
                    ],
                    "last": "Andrade",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "A"
                    ],
                    "last": "Ault",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "R"
                    ],
                    "last": "Giuliano",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "M"
                    ],
                    "last": "Wheeler",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "A"
                    ],
                    "last": "Koutsky",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Malm",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Lehtinen",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Lancet Oncol",
            "volume": "6",
            "issn": "",
            "pages": "271--278",
            "other_ids": {}
        },
        "BIBREF13": {
            "ref_id": "b13",
            "title": "Human hepatitis B vaccine from recombinant yeast",
            "authors": [
                {
                    "first": "W",
                    "middle": [
                        "J"
                    ],
                    "last": "Mcaleer",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "B"
                    ],
                    "last": "Buynak",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "Z"
                    ],
                    "last": "Maigetter",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "E"
                    ],
                    "last": "Wampler",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "J"
                    ],
                    "last": "Miller",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "R"
                    ],
                    "last": "Hilleman",
                    "suffix": ""
                }
            ],
            "year": 1984,
            "venue": "Nature",
            "volume": "307",
            "issn": "",
            "pages": "178--180",
            "other_ids": {}
        },
        "BIBREF14": {
            "ref_id": "b14",
            "title": "Summary of clinical findings on Engerix-B, a genetically engineered yeast derived hepatitis B vaccine",
            "authors": [
                {
                    "first": "F",
                    "middle": [
                        "E"
                    ],
                    "last": "Andre",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Safary",
                    "suffix": ""
                }
            ],
            "year": 1987,
            "venue": "Postgrad Med J",
            "volume": "63",
            "issn": "2",
            "pages": "169--177",
            "other_ids": {}
        },
        "BIBREF15": {
            "ref_id": "b15",
            "title": "First HEV vaccine approved",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Proffitt",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Nature Biotechnology",
            "volume": "30",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF16": {
            "ref_id": "b16",
            "title": "Characterization of porcine circovirus type 2 (PCV2) capsid particle assembly and its application to virus-like particle vaccine development",
            "authors": [
                {
                    "first": "P",
                    "middle": [
                        "C"
                    ],
                    "last": "Wu",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "L"
                    ],
                    "last": "Lin",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "M"
                    ],
                    "last": "Wu",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "N"
                    ],
                    "last": "Chi",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "S"
                    ],
                    "last": "Chien",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Huang",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Appl Microbiol Biotechnol",
            "volume": "95",
            "issn": "",
            "pages": "1501--1507",
            "other_ids": {}
        },
        "BIBREF17": {
            "ref_id": "b17",
            "title": "Porcine circovirus type 2 (PCV2) viral components immunomodulate recall antigen responses",
            "authors": [
                {
                    "first": "T",
                    "middle": [],
                    "last": "Kekarainen",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Montoya",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Dominguez",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Mateu",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Segales",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Vet Immunol Immunopathol",
            "volume": "124",
            "issn": "",
            "pages": "41--49",
            "other_ids": {}
        },
        "BIBREF19": {
            "ref_id": "b19",
            "title": "A virus-like particlebased Epstein-Barr virus vaccine",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Ruiss",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Jochum",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Wanner",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Reisbach",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Hammerschmidt",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Zeidler",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "J Virol",
            "volume": "85",
            "issn": "",
            "pages": "13105--13113",
            "other_ids": {}
        },
        "BIBREF20": {
            "ref_id": "b20",
            "title": "Induction of a protective immune response against viral nervous necrosis in the European sea bass Dicentrarchus labrax by using betanodavirus virus-like particles",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Thiery",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Cozien",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Cabon",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Lamour",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Baud",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Schneemann",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "J Virol",
            "volume": "80",
            "issn": "",
            "pages": "10201--10207",
            "other_ids": {}
        },
        "BIBREF21": {
            "ref_id": "b21",
            "title": "Virus-like particles of a fish nodavirus display a capsid subunit domain organization different from that of insect nodaviruses",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Tang",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "S"
                    ],
                    "last": "Lin",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [
                        "K"
                    ],
                    "last": "Krishna",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Yeager",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Schneemann",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "E"
                    ],
                    "last": "Johnson",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "J Virol",
            "volume": "76",
            "issn": "",
            "pages": "6370--6375",
            "other_ids": {}
        },
        "BIBREF22": {
            "ref_id": "b22",
            "title": "A viral nanoparticle with dual function as an anthrax antitoxin and vaccine",
            "authors": [
                {
                    "first": "D",
                    "middle": [
                        "J"
                    ],
                    "last": "Manayani",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Thomas",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "A"
                    ],
                    "last": "Dryden",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Reddy",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "E"
                    ],
                    "last": "Siladi",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Marlett",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "J"
                    ],
                    "last": "Rainey",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "E"
                    ],
                    "last": "Pique",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "M"
                    ],
                    "last": "Scobie",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Yeager",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "PLoS Pathog",
            "volume": "3",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF23": {
            "ref_id": "b23",
            "title": "Influenza virus-like particles as pandemic vaccines",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "M"
                    ],
                    "last": "Kang",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Pushko",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "A"
                    ],
                    "last": "Bright",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Smith",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "W"
                    ],
                    "last": "Compans",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Curr Top Microbiol Immunol",
            "volume": "333",
            "issn": "",
            "pages": "269--289",
            "other_ids": {}
        },
        "BIBREF24": {
            "ref_id": "b24",
            "title": "Intranasal vaccination with 1918 influenza virus-like particles protects mice and ferrets from lethal 1918 and H5N1 influenza virus challenge",
            "authors": [
                {
                    "first": "L",
                    "middle": [
                        "A"
                    ],
                    "last": "Perrone",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Ahmad",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Veguilla",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Lu",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Smith",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Katz",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Pushko",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "M"
                    ],
                    "last": "Tumpey",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "J Virol",
            "volume": "",
            "issn": "",
            "pages": "5726--5734",
            "other_ids": {}
        },
        "BIBREF25": {
            "ref_id": "b25",
            "title": "Influenza viruslike particle can accommodate multiple subtypes of hemagglutinin and protect from multiple influenza types and subtypes",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Pushko",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "B"
                    ],
                    "last": "Pearce",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Ahmad",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [],
                    "last": "Tretyakova",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Smith",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "A"
                    ],
                    "last": "Belser",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "M"
                    ],
                    "last": "Tumpey",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Vaccine",
            "volume": "29",
            "issn": "",
            "pages": "5911--5918",
            "other_ids": {}
        },
        "BIBREF26": {
            "ref_id": "b26",
            "title": "Virus-like particle vaccine confers protection against a lethal NDV challenge in chickens and allows DIVA strategy",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "K"
                    ],
                    "last": "Park",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "H"
                    ],
                    "last": "Lee",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "S"
                    ],
                    "last": "Yuk",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "O"
                    ],
                    "last": "To",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "H"
                    ],
                    "last": "Kwon",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "Y"
                    ],
                    "last": "Noh",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [
                        "Y"
                    ],
                    "last": "Kim",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "W"
                    ],
                    "last": "Choi",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "M"
                    ],
                    "last": "Kang",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "B"
                    ],
                    "last": "Lee",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Clin Vaccine Immunol",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF27": {
            "ref_id": "b27",
            "title": "Viruslike particle vaccine induces protection against respiratory syncytial virus infection in mice",
            "authors": [
                {
                    "first": "F",
                    "middle": [
                        "S"
                    ],
                    "last": "Quan",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Kim",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Lee",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Yi",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "M"
                    ],
                    "last": "Kang",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Bozja",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "L"
                    ],
                    "last": "Moore",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "W"
                    ],
                    "last": "Compans",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "J Infect Dis",
            "volume": "204",
            "issn": "",
            "pages": "987--995",
            "other_ids": {}
        },
        "BIBREF28": {
            "ref_id": "b28",
            "title": "A novel recombinant virus-like particle vaccine for prevention of porcine parvovirus-induced reproductive failure",
            "authors": [
                {
                    "first": "A",
                    "middle": [
                        "F"
                    ],
                    "last": "Antonis",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "J"
                    ],
                    "last": "Bruschke",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Rueda",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Maranga",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "I"
                    ],
                    "last": "Casal",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Vela",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "A"
                    ],
                    "last": "Hilgers",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "B"
                    ],
                    "last": "Belt",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Weerdmeester",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "J"
                    ],
                    "last": "Carrondo",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Vaccine",
            "volume": "24",
            "issn": "",
            "pages": "5481--5490",
            "other_ids": {}
        },
        "BIBREF29": {
            "ref_id": "b29",
            "title": "Canine parvovirus empty capsids produced by expression in a baculovirus vector: use in analysis of viral properties and immunization of dogs",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "T"
                    ],
                    "last": "Saliki",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Mizak",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "P"
                    ],
                    "last": "Flore",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "R"
                    ],
                    "last": "Gettig",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "P"
                    ],
                    "last": "Burand",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "E"
                    ],
                    "last": "Carmichael",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "A"
                    ],
                    "last": "Wood",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "R"
                    ],
                    "last": "Parrish",
                    "suffix": ""
                }
            ],
            "year": 1992,
            "venue": "J Gen Virol",
            "volume": "73",
            "issn": "2",
            "pages": "369--374",
            "other_ids": {}
        },
        "BIBREF30": {
            "ref_id": "b30",
            "title": "Recombinant vaccine for canine parvovirus in dogs",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "A"
                    ],
                    "last": "Lopez De Turiso",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Cortes",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Martinez",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Ruiz De Ybanez",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [],
                    "last": "Simarro",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Vela",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [],
                    "last": "Casal",
                    "suffix": ""
                }
            ],
            "year": 1992,
            "venue": "J Virol",
            "volume": "66",
            "issn": "",
            "pages": "2748--2753",
            "other_ids": {}
        },
        "BIBREF31": {
            "ref_id": "b31",
            "title": "Selfassembly of virus-like particles of canine parvovirus capsid protein expressed from Escherichia coli and application as virus-like particle vaccine",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Xu",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "C"
                    ],
                    "last": "Guo",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "Q"
                    ],
                    "last": "Wei",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Dong",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "C"
                    ],
                    "last": "Han",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Ao",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "H"
                    ],
                    "last": "Sun",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "M"
                    ],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "Z"
                    ],
                    "last": "Cao",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "Q"
                    ],
                    "last": "Sun",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Appl Microbiol Biotechnol",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF32": {
            "ref_id": "b32",
            "title": "Goose parvovirus structural proteins expressed by recombinant baculoviruses self-assemble into virus-like particles with strong immunogenicity in goose",
            "authors": [
                {
                    "first": "H",
                    "middle": [],
                    "last": "Ju",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Wei",
                    "suffix": ""
                },
                {
                    "first": "Q",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Jing",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Guo",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Gao",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Ma",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Biochem Biophys Res Commun",
            "volume": "409",
            "issn": "",
            "pages": "131--136",
            "other_ids": {}
        },
        "BIBREF33": {
            "ref_id": "b33",
            "title": "Generation of a parvovirus B19 vaccine candidate",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Chandramouli",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Medina-Selby",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Coit",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Schaefer",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Spencer",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "A"
                    ],
                    "last": "Brito",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Otten",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "W"
                    ],
                    "last": "Mandl",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "W"
                    ],
                    "last": "Mason",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Vaccine",
            "volume": "31",
            "issn": "",
            "pages": "3872--3878",
            "other_ids": {}
        },
        "BIBREF34": {
            "ref_id": "b34",
            "title": "Safety and immunogenicity of a candidate parvovirus B19 vaccine",
            "authors": [
                {
                    "first": "D",
                    "middle": [
                        "I"
                    ],
                    "last": "Bernstein",
                    "suffix": ""
                },
                {
                    "first": "El",
                    "middle": [],
                    "last": "Sahly",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "M"
                    ],
                    "last": "Keitel",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "A"
                    ],
                    "last": "Wolff",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Simone",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Segawa",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Wong",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Shelly",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Young",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [
                        "S"
                    ],
                    "last": "Dempsey",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Vaccine",
            "volume": "29",
            "issn": "",
            "pages": "7357--7363",
            "other_ids": {}
        },
        "BIBREF35": {
            "ref_id": "b35",
            "title": "Human papillomavirus type 11 recombinant L1 capsomeres induce virus-neutralizing antibodies",
            "authors": [
                {
                    "first": "R",
                    "middle": [
                        "C"
                    ],
                    "last": "Rose",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "I"
                    ],
                    "last": "White",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "A"
                    ],
                    "last": "Suzich",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Lane",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "L"
                    ],
                    "last": "Garcea",
                    "suffix": ""
                }
            ],
            "year": 1998,
            "venue": "J Virol",
            "volume": "72",
            "issn": "",
            "pages": "6151--6154",
            "other_ids": {}
        },
        "BIBREF36": {
            "ref_id": "b36",
            "title": "Immunization with a pentameric L1 fusion protein protects against papillomavirus infection",
            "authors": [
                {
                    "first": "H",
                    "middle": [],
                    "last": "Yuan",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "A"
                    ],
                    "last": "Estes",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Newsome",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [
                        "A"
                    ],
                    "last": "Olcese",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "L"
                    ],
                    "last": "Garcea",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Schlegel",
                    "suffix": ""
                }
            ],
            "year": 2001,
            "venue": "J Virol",
            "volume": "75",
            "issn": "",
            "pages": "7848--7853",
            "other_ids": {}
        },
        "BIBREF37": {
            "ref_id": "b37",
            "title": "Immunogenicity and safety of virus-like particle of the porcine encephalomyocarditis virus in pig",
            "authors": [
                {
                    "first": "H",
                    "middle": [
                        "Y"
                    ],
                    "last": "Jeoung",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "H"
                    ],
                    "last": "Lee",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Jeong",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [
                        "H"
                    ],
                    "last": "Shin",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "W"
                    ],
                    "last": "Choi",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "S"
                    ],
                    "last": "Lee",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "J"
                    ],
                    "last": "An",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Virol J",
            "volume": "8",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF38": {
            "ref_id": "b38",
            "title": "Vaccination with coxsackievirus B3 virus-like particles elicits humoral immune response and protects mice against myocarditis",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [
                        "J"
                    ],
                    "last": "Parham",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Aasa-Chapman",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "A"
                    ],
                    "last": "Gould",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Vaccine",
            "volume": "30",
            "issn": "",
            "pages": "2301--2308",
            "other_ids": {}
        },
        "BIBREF39": {
            "ref_id": "b39",
            "title": "A virus-like particle vaccine for coxsackievirus A16 potently elicits neutralizing antibodies that protect mice against lethal challenge",
            "authors": [
                {
                    "first": "Q",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Yan",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Feng",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Huang",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Ku",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Cai",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Shi",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Huang",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Vaccine",
            "volume": "30",
            "issn": "",
            "pages": "6642--6648",
            "other_ids": {}
        },
        "BIBREF40": {
            "ref_id": "b40",
            "title": "Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge",
            "authors": [
                {
                    "first": "Y",
                    "middle": [
                        "C"
                    ],
                    "last": "Chung",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "S"
                    ],
                    "last": "Ho",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "C"
                    ],
                    "last": "Wu",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "J"
                    ],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "H"
                    ],
                    "last": "Huang",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "T"
                    ],
                    "last": "Chou",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "C"
                    ],
                    "last": "Hu",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Vaccine",
            "volume": "26",
            "issn": "",
            "pages": "1855--1862",
            "other_ids": {}
        },
        "BIBREF41": {
            "ref_id": "b41",
            "title": "Enterovirus type 71 neutralizing antibodies in the serum of macaque monkeys immunized with EV71 virus-like particles",
            "authors": [
                {
                    "first": "Y",
                    "middle": [
                        "L"
                    ],
                    "last": "Lin",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "I"
                    ],
                    "last": "Yu",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "C"
                    ],
                    "last": "Hu",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "J"
                    ],
                    "last": "Tsai",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "C"
                    ],
                    "last": "Kuo",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "K"
                    ],
                    "last": "Chi",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "N"
                    ],
                    "last": "Lin",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [
                        "L"
                    ],
                    "last": "Chiang",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Vaccine",
            "volume": "30",
            "issn": "",
            "pages": "1305--1312",
            "other_ids": {}
        },
        "BIBREF42": {
            "ref_id": "b42",
            "title": "Virus-like particles for enterovirus 71 produced from Saccharomyces cerevisiae potently elicits protective immune responses in mice",
            "authors": [
                {
                    "first": "H",
                    "middle": [
                        "Y"
                    ],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "F"
                    ],
                    "last": "Han",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "F"
                    ],
                    "last": "Qin",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Vaccine",
            "volume": "31",
            "issn": "",
            "pages": "3281--3287",
            "other_ids": {}
        },
        "BIBREF43": {
            "ref_id": "b43",
            "title": "Novel immunogenic baculovirus expressed virus-like particles of foot-andmouth disease (FMD) virus protect guinea pigs against challenge",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "A"
                    ],
                    "last": "Bhat",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Saravanan",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Hosamani",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "H"
                    ],
                    "last": "Basagoudanavar",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [
                        "P"
                    ],
                    "last": "Sreenivasa",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "P"
                    ],
                    "last": "Tamilselvan",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Venkataramanan",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Res Vet Sci",
            "volume": "95",
            "issn": "",
            "pages": "1217--1223",
            "other_ids": {}
        },
        "BIBREF44": {
            "ref_id": "b44",
            "title": "Foot-and-mouth disease virus-like particles produced by a SUMO fusion protein system in Escherichia coli induce potent protective immune responses in guinea pigs, swine and cattle",
            "authors": [
                {
                    "first": "H",
                    "middle": [
                        "C"
                    ],
                    "last": "Guo",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "Q"
                    ],
                    "last": "Sun",
                    "suffix": ""
                },
                {
                    "first": "Jin",
                    "middle": [
                        "Y"
                    ],
                    "last": "Yang",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "L"
                    ],
                    "last": "Wei",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "Q"
                    ],
                    "last": "Sun",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "H"
                    ],
                    "last": "Yin",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "H"
                    ],
                    "last": "Ma",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "W"
                    ],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [
                        "X"
                    ],
                    "last": "Guo",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "H"
                    ],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Vet Res",
            "volume": "44",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF45": {
            "ref_id": "b45",
            "title": "Formation of immunogenic virus-like particles by inserting epitopes into surface-exposed regions of hamster polyomavirus major capsid protein",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Gedvilaite",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Frommel",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Sasnauskas",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Micheel",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Ozel",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [],
                    "last": "Behrsing",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Staniulis",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Jandrig",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Scherneck",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Ulrich",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "Virology",
            "volume": "273",
            "issn": "",
            "pages": "21--35",
            "other_ids": {}
        },
        "BIBREF46": {
            "ref_id": "b46",
            "title": "Segments of puumala hantavirus nucleocapsid protein inserted into chimeric polyomavirus-derived virus-like particles induce a strong immune response in mice",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Gedvilaite",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Zvirbliene",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Staniulis",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Sasnauskas",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "H"
                    ],
                    "last": "Kruger",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Ulrich",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Viral Immunol",
            "volume": "17",
            "issn": "",
            "pages": "51--68",
            "other_ids": {}
        },
        "BIBREF47": {
            "ref_id": "b47",
            "title": "Cellular and humoral immunogenicity of hamster polyomavirusderived virus-like particles harboring a mucin 1 cytotoxic T-cell epitope",
            "authors": [
                {
                    "first": "D",
                    "middle": [
                        "C"
                    ],
                    "last": "Dorn",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Lawatscheck",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Zvirbliene",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Aleksaite",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Pecher",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Sasnauskas",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Ozel",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Raftery",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Schonrich",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "G"
                    ],
                    "last": "Ulrich",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Viral Immunol",
            "volume": "21",
            "issn": "",
            "pages": "12--27",
            "other_ids": {}
        },
        "BIBREF48": {
            "ref_id": "b48",
            "title": "Induction of insert-specific immune response in mice by hamster polyomavirus VP1 derived virus-like particles carrying LCMV GP33 CTL epitope",
            "authors": [
                {
                    "first": "E",
                    "middle": [],
                    "last": "Mazeike",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Gedvilaite",
                    "suffix": ""
                },
                {
                    "first": "U",
                    "middle": [],
                    "last": "Blohm",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Virus Res",
            "volume": "163",
            "issn": "",
            "pages": "2--10",
            "other_ids": {}
        },
        "BIBREF49": {
            "ref_id": "b49",
            "title": "Self-adjuvanting modular virus-like particles for mucosal vaccination against group A streptococcus (GAS)",
            "authors": [
                {
                    "first": "T",
                    "middle": [],
                    "last": "Rivera-Hernandez",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Hartas",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Wu",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "P"
                    ],
                    "last": "Chuan",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "H"
                    ],
                    "last": "Lua",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Good",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "R"
                    ],
                    "last": "Batzloff",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "P"
                    ],
                    "last": "Middelberg",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Vaccine",
            "volume": "31",
            "issn": "",
            "pages": "1950--1955",
            "other_ids": {}
        },
        "BIBREF50": {
            "ref_id": "b50",
            "title": "A single vaccination with polyomavirus VP1/VP2Her2 virus-like particles prevents outgrowth of HER-2/neu-expressing tumors",
            "authors": [
                {
                    "first": "K",
                    "middle": [],
                    "last": "Tegerstedt",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "A"
                    ],
                    "last": "Lindencrona",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Curcio",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Andreasson",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Tullus",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Forni",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Dalianis",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Kiessling",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Ramqvist",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Cancer Res",
            "volume": "65",
            "issn": "",
            "pages": "5953--5957",
            "other_ids": {}
        },
        "BIBREF51": {
            "ref_id": "b51",
            "title": "Murine polyomavirus virus-like particles carrying full-length human PSA protect BALB/c mice from outgrowth of a PSA expressing tumor",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Eriksson",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Andreasson",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Weidmann",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Lundberg",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Tegerstedt",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Dalianis",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Ramqvist",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "PLoS One",
            "volume": "6",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF52": {
            "ref_id": "b52",
            "title": "Development of a vaccine marker technology: display of B cell epitopes on the surface of recombinant polyomavirus-like pentamers and capsoids induces peptide-specific antibodies in piglets after vaccination",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Neugebauer",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Walders",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Brinkman",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Ruehland",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Schumacher",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "M"
                    ],
                    "last": "Bertling",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Geuther",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "O"
                    ],
                    "last": "Reiser",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Reichel",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Strich",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Biotechnol J",
            "volume": "1",
            "issn": "",
            "pages": "1435--1446",
            "other_ids": {}
        },
        "BIBREF53": {
            "ref_id": "b53",
            "title": "SV40 virus-like particles as an effective delivery system and its application to a vaccine carrier",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Kawano",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Matsui",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Handa",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Expert Rev Vaccines",
            "volume": "12",
            "issn": "",
            "pages": "199--210",
            "other_ids": {}
        },
        "BIBREF54": {
            "ref_id": "b54",
            "title": "Self-assembled virus-like particles from rotavirus structural protein VP6 for targeted drug delivery",
            "authors": [
                {
                    "first": "Q",
                    "middle": [],
                    "last": "Zhao",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Bioconjug Chem",
            "volume": "22",
            "issn": "",
            "pages": "346--352",
            "other_ids": {}
        },
        "BIBREF55": {
            "ref_id": "b55",
            "title": "VP6: A candidate rotavirus vaccine",
            "authors": [
                {
                    "first": "R",
                    "middle": [
                        "L"
                    ],
                    "last": "Ward",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "M"
                    ],
                    "last": "Mcneal",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "J Infect Dis",
            "volume": "202",
            "issn": "",
            "pages": "101--107",
            "other_ids": {}
        },
        "BIBREF56": {
            "ref_id": "b56",
            "title": "Human rotavirus virus-like particle vaccines evaluated in a neonatal gnotobiotic pig model of human rotavirus disease",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "P"
                    ],
                    "last": "Azevedo",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "N"
                    ],
                    "last": "Vlasova",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "J"
                    ],
                    "last": "Saif",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Expert Rev Vaccines",
            "volume": "12",
            "issn": "",
            "pages": "169--181",
            "other_ids": {}
        },
        "BIBREF57": {
            "ref_id": "b57",
            "title": "Protective efficacy of virus-like particles for bluetongue disease",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Roy",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "French",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [
                        "J"
                    ],
                    "last": "Erasmus",
                    "suffix": ""
                }
            ],
            "year": 1992,
            "venue": "Vaccine",
            "volume": "10",
            "issn": "",
            "pages": "28--32",
            "other_ids": {}
        },
        "BIBREF58": {
            "ref_id": "b58",
            "title": "Recombinant virus vaccine for bluetongue disease in sheep",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Roy",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Urakawa",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "A"
                    ],
                    "last": "Van Dijk",
                    "suffix": ""
                },
                {
                    "first": "Erasmus",
                    "middle": [],
                    "last": "Bj",
                    "suffix": ""
                }
            ],
            "year": 1990,
            "venue": "J Virol",
            "volume": "64",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF59": {
            "ref_id": "b59",
            "title": "Bluetongue virus serotype 8 virus-like particles protect sheep against virulent virus infection as a single or multi-serotype cocktail immunogen",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Stewart",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Dubois",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Sailleau",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Breard",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Viarouge",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Desprat",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Thiery",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Zientara",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Roy",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Vaccine",
            "volume": "31",
            "issn": "",
            "pages": "553--558",
            "other_ids": {}
        },
        "BIBREF60": {
            "ref_id": "b60",
            "title": "Virus-like particles as HIV-1 vaccines",
            "authors": [
                {
                    "first": "L",
                    "middle": [
                        "X"
                    ],
                    "last": "Doan",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "Q",
                    "middle": [],
                    "last": "Yao",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Rev Med Virol",
            "volume": "15",
            "issn": "",
            "pages": "75--88",
            "other_ids": {}
        },
        "BIBREF61": {
            "ref_id": "b61",
            "title": "A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection",
            "authors": [
                {
                    "first": "W",
                    "middle": [],
                    "last": "Akahata",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [
                        "Y"
                    ],
                    "last": "Yang",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Andersen",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Sun",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "A"
                    ],
                    "last": "Holdaway",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "P"
                    ],
                    "last": "Kong",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "G"
                    ],
                    "last": "Lewis",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Higgs",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "G"
                    ],
                    "last": "Rossmann",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Rao",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Nat Med",
            "volume": "16",
            "issn": "",
            "pages": "334--338",
            "other_ids": {}
        },
        "BIBREF62": {
            "ref_id": "b62",
            "title": "Safety, immunogenicity, and efficacy of a recombinantly produced Plasmodium falciparum circumsporozoite protein-hepatitis B surface antigen subunit vaccine",
            "authors": [
                {
                    "first": "D",
                    "middle": [
                        "M"
                    ],
                    "last": "Gordon",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "W"
                    ],
                    "last": "Mcgovern",
                    "suffix": ""
                },
                {
                    "first": "U",
                    "middle": [],
                    "last": "Krzych",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "C"
                    ],
                    "last": "Cohen",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [],
                    "last": "Schneider",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Lachance",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "G"
                    ],
                    "last": "Heppner",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Yuan",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Hollingdale",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Slaoui",
                    "suffix": ""
                }
            ],
            "year": 1995,
            "venue": "J Infect Dis",
            "volume": "171",
            "issn": "",
            "pages": "1576--1585",
            "other_ids": {}
        },
        "BIBREF63": {
            "ref_id": "b63",
            "title": "A phase I/IIa safety, immunogenicity, and efficacy bridging randomized study of a two-dose regimen of liquid and lyophilized formulations of the candidate malaria vaccine RTS,S/AS02A in malaria-naive adults",
            "authors": [
                {
                    "first": "K",
                    "middle": [
                        "E"
                    ],
                    "last": "Kester",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "A"
                    ],
                    "last": "Mckinney",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Tornieporth",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "F"
                    ],
                    "last": "Ockenhouse",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "G"
                    ],
                    "last": "Heppner",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Hall",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [
                        "T"
                    ],
                    "last": "Wellde",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "White",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Sun",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Schwenk",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Vaccine",
            "volume": "25",
            "issn": "",
            "pages": "5359--5366",
            "other_ids": {}
        },
        "BIBREF64": {
            "ref_id": "b64",
            "title": "Der p 1 peptide on virus-like particles is safe and highly immunogenic in healthy adults",
            "authors": [
                {
                    "first": "T",
                    "middle": [
                        "M"
                    ],
                    "last": "Kundig",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Senti",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Schnetzler",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Wolf",
                    "suffix": ""
                },
                {
                    "first": "Prinz",
                    "middle": [],
                    "last": "Vavricka",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [
                        "M"
                    ],
                    "last": "Fulurija",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Hennecke",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Sladko",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Jennings",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "T"
                    ],
                    "last": "Bachmann",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "F"
                    ],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "J Allergy Clin Immunol",
            "volume": "117",
            "issn": "",
            "pages": "1470--1476",
            "other_ids": {}
        },
        "BIBREF65": {
            "ref_id": "b65",
            "title": "Plant-derived vaccine protects target animals against a viral disease",
            "authors": [
                {
                    "first": "K",
                    "middle": [],
                    "last": "Dalsgaard",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Uttenthal",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "D"
                    ],
                    "last": "Jones",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Xu",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Merryweather",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "D"
                    ],
                    "last": "Hamilton",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "P"
                    ],
                    "last": "Langeveld",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "S"
                    ],
                    "last": "Boshuizen",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Kamstrup",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "P"
                    ],
                    "last": "Lomonossoff",
                    "suffix": ""
                }
            ],
            "year": 1997,
            "venue": "Nat Biotechnol",
            "volume": "15",
            "issn": "",
            "pages": "248--252",
            "other_ids": {}
        },
        "BIBREF66": {
            "ref_id": "b66",
            "title": "Pseudomonas aeruginosa outer-membrane protein F epitopes are highly immunogenic in mice when expressed on a plant virus",
            "authors": [
                {
                    "first": "F",
                    "middle": [
                        "R"
                    ],
                    "last": "Brennan",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "D"
                    ],
                    "last": "Jones",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "B"
                    ],
                    "last": "Gilleland",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Bellaby",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Xu",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "C"
                    ],
                    "last": "North",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Thompson",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Staczek",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Lin",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "E"
                    ],
                    "last": "Johnson",
                    "suffix": ""
                }
            ],
            "year": 1999,
            "venue": "Microbiology",
            "volume": "145",
            "issn": "",
            "pages": "211--220",
            "other_ids": {}
        },
        "BIBREF67": {
            "ref_id": "b67",
            "title": "Antibodies against a truncated Staphylococcus aureus fibronectin-binding protein protect against dissemination of infection in the rat",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Rennermalm",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "H"
                    ],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Bohaufs",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Jarstrand",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Brauner",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [
                        "R"
                    ],
                    "last": "Brennan",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "I"
                    ],
                    "last": "Flock",
                    "suffix": ""
                }
            ],
            "year": 2001,
            "venue": "Vaccine",
            "volume": "19",
            "issn": "",
            "pages": "3376--3383",
            "other_ids": {}
        },
        "BIBREF68": {
            "ref_id": "b68",
            "title": "Production and immunogenicity of chimeric virus-like particles (VLPs) containing the spike (S1) glycoprotein of infectious bronchitis virus (IBV)",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Lv",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "Q",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Shen",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Xue",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Cao",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "J Vet Sci",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF69": {
            "ref_id": "b69",
            "title": "Assembly and immunological properties of a bivalent virus-like particle (VLP) for avian influenza and Newcastle disease",
            "authors": [
                {
                    "first": "H",
                    "middle": [],
                    "last": "Shen",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Xue",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Lv",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "Q",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Zheng",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Cao",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Virus Res",
            "volume": "178",
            "issn": "",
            "pages": "430--436",
            "other_ids": {}
        },
        "BIBREF70": {
            "ref_id": "b70",
            "title": "Construction, expression and immunogenicity of a novel anti-hypertension angiotensin II vaccine based on hepatitis A viruslike particle",
            "authors": [
                {
                    "first": "X",
                    "middle": [],
                    "last": "Ou",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Guo",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Wu",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Mi",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Yin",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Sun",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Hum Vaccin Immunother",
            "volume": "9",
            "issn": "",
            "pages": "1191--1199",
            "other_ids": {}
        },
        "BIBREF71": {
            "ref_id": "b71",
            "title": "Chimeric Virus-Like Particle Vaccines Displaying Conserved Enterovirus 71 Epitopes Elicit Protective Neutralizing Antibodies in Mice through Divergent Mechanisms",
            "authors": [
                {
                    "first": "X",
                    "middle": [],
                    "last": "Ye",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Ku",
                    "suffix": ""
                },
                {
                    "first": "Q",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Shi",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Kong",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Cong",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Huang",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "J Virol",
            "volume": "88",
            "issn": "",
            "pages": "72--81",
            "other_ids": {}
        },
        "BIBREF72": {
            "ref_id": "b72",
            "title": "Construction and immunological evaluation of multivalent hepatitis B virus (HBV) core viruslike particles carrying HBV and HCV epitopes",
            "authors": [
                {
                    "first": "I",
                    "middle": [],
                    "last": "Sominskaya",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Skrastina",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Dislers",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Vasiljev",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Mihailova",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Ose",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Dreilina",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Pumpens",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Clin Vaccine Immunol",
            "volume": "17",
            "issn": "",
            "pages": "1027--1033",
            "other_ids": {}
        },
        "BIBREF73": {
            "ref_id": "b73",
            "title": "Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies",
            "authors": [
                {
                    "first": "P",
                    "middle": [
                        "T"
                    ],
                    "last": "Vietheer",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [],
                    "last": "Boo",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "E"
                    ],
                    "last": "Drummer",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "J"
                    ],
                    "last": "Netter",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Antivir Ther",
            "volume": "12",
            "issn": "",
            "pages": "477--487",
            "other_ids": {}
        },
        "BIBREF74": {
            "ref_id": "b74",
            "title": "Chimeric Hepatitis B core antigen virus-like particles displaying the envelope domain III of dengue virus type 2",
            "authors": [
                {
                    "first": "U",
                    "middle": [],
                    "last": "Arora",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Tyagi",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Swaminathan",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Khanna",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "J Nanobiotechnology",
            "volume": "10",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF75": {
            "ref_id": "b75",
            "title": "Virus-like particles displaying envelope domain III of dengue virus type 2 induce virus-specific antibody response in mice",
            "authors": [
                {
                    "first": "U",
                    "middle": [],
                    "last": "Arora",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Tyagi",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Swaminathan",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Khanna",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Vaccine",
            "volume": "31",
            "issn": "",
            "pages": "873--878",
            "other_ids": {}
        },
        "BIBREF76": {
            "ref_id": "b76",
            "title": "Chimeric derivatives of hepatitis B virus core particles carrying major epitopes of the rubella virus E1 glycoprotein",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Skrastina",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [],
                    "last": "Petrovskis",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Petraityte",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [],
                    "last": "Sominskaya",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Ose",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [],
                    "last": "Lieknina",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Bogans",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Sasnauskas",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Pumpens",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Clin Vaccine Immunol",
            "volume": "20",
            "issn": "",
            "pages": "1719--1728",
            "other_ids": {}
        },
        "BIBREF77": {
            "ref_id": "b77",
            "title": "Virus-like particles of hepatitis B virus core protein containing five mimotopes of infectious bursal disease virus (IBDV) protect chickens against IBDV",
            "authors": [
                {
                    "first": "Y",
                    "middle": [
                        "S"
                    ],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Ouyang",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [
                        "J"
                    ],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "W"
                    ],
                    "last": "He",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "Q"
                    ],
                    "last": "Yu",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "B"
                    ],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "J"
                    ],
                    "last": "Fan",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "P"
                    ],
                    "last": "Lu",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Vaccine",
            "volume": "30",
            "issn": "",
            "pages": "2125--2130",
            "other_ids": {}
        },
        "BIBREF78": {
            "ref_id": "b78",
            "title": "Vaccine delivery system for tuberculosis based on nano-sized hepatitis B virus core protein particles",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Dhanasooraj",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "A"
                    ],
                    "last": "Kumar",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Mundayoor",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Int J Nanomedicine",
            "volume": "8",
            "issn": "",
            "pages": "835--843",
            "other_ids": {}
        },
        "BIBREF79": {
            "ref_id": "b79",
            "title": "A novel platform for virus-like particle-display of flaviviral envelope domain III: induction of Dengue and West Nile virus neutralizing antibodies",
            "authors": [
                {
                    "first": "A",
                    "middle": [
                        "J"
                    ],
                    "last": "Chua",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Vituret",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "L"
                    ],
                    "last": "Tan",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Gonzalez",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Boulanger",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "L"
                    ],
                    "last": "Ng",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "S"
                    ],
                    "last": "Hong",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Virol J",
            "volume": "10",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF80": {
            "ref_id": "b80",
            "title": "Virus-like particle vaccine induces cross-protection against human metapneumovirus infections in mice",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Levy",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Aerts",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "E"
                    ],
                    "last": "Hamelin",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Granier",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Szecsi",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Lavillette",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Boivin",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [
                        "L"
                    ],
                    "last": "Cosset",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Vaccine",
            "volume": "31",
            "issn": "",
            "pages": "2778--2785",
            "other_ids": {}
        },
        "BIBREF81": {
            "ref_id": "b81",
            "title": "A dual vaccine candidate against norovirus and hepatitis E virus",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Cao",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Wei",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [
                        "J"
                    ],
                    "last": "Meng",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Jiang",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Tan",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF82": {
            "ref_id": "b82",
            "title": "Sensitivity of immune response quality to influenza helix 190 antigen structure displayed on a modular virus-like particle",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "R"
                    ],
                    "last": "Anggraeni",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [
                        "K"
                    ],
                    "last": "Connors",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Wu",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "P"
                    ],
                    "last": "Chuan",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "H"
                    ],
                    "last": "Lua",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "P"
                    ],
                    "last": "Middelberg",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Vaccine",
            "volume": "31",
            "issn": "",
            "pages": "4428--4435",
            "other_ids": {}
        },
        "BIBREF83": {
            "ref_id": "b83",
            "title": "Chimeric SV40 virus-like particles induce specific cytotoxicity and protective immunity against influenza A virus without the need of adjuvants",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Kawano",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Morikawa",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Suda",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Ohno",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Matsushita",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Akatsuka",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Handa",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Matsui",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Virology",
            "volume": "448",
            "issn": "",
            "pages": "159--167",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "TABREF0": {
            "text": "Virus illness. N Engl J Med. 2011; 365:2178-2187. [PubMed: 22150036] [This paper reported the first phase II clinical trials of norovirus VLP vaccine and demonstrated for the first time that norovirus VLP vaccine protects vaccinees against norovirus infection and illness.] 20. Safary A: Perspectives of vaccination against hepatitis E. Intervirology. 2001; 44:162-166. [PubMed: 11509877] 21. Shrestha MP, Scott RM, Joshi DM, Mammen MP Jr. Thapa GB, Thapa N, Myint KS, Fourneau M, Kuschner RA, Shrestha SK, et al. Safety and efficacy of a recombinant hepatitis E vaccine. N Engl J Med. 2007; 356:895-903. [PubMed: 17329696] 22. Kratz PA, Bottcher B, Nassal M. Native display of complete foreign protein domains on the surface of hepatitis B virus capsids. Proc Natl Acad Sci U S A. 1999; 96:1915-1920. [PubMed: 10051569] 23*. Cohen J, Nussenzweig V, Nussenzweig R, Vekemans J, Leach A. From the circumsporozoite protein to the RTS, S/AS candidate vaccine. Hum Vaccin. 2010; 6:90-96. [PubMed: 19806009] [This review article summarizes the development process of the first subviral particle basedmalaria vaccine from bench to patients. This includes the rational selection of the Birkett A, Lyons K, Schmidt A, Boyd D, Oliveira GA, Siddique A, Nussenzweig R, Calvo-Calle JM, Nardin E. A modified hepatitis B virus core particle containing multiple epitopes of the Plasmodium falciparum circumsporozoite protein provides a highly immunogenic malaria vaccine in preclinical analyses in rodent and primate hosts. Infect Immun. 2002; 70:6860-6870. [PubMed: 12438363] 26. Nardin EH, Oliveira GA, Calvo-Calle JM, Wetzel K, Maier C, Birkett AJ, Sarpotdar P, Corado ML, Thornton GB, Schmidt A. Phase I testing of a malaria vaccine composed of hepatitis B virus core particles expressing Plasmodium falciparum circumsporozoite epitopes. Fu TM, Grimm KM, Citron MP, Freed DC, Fan J, Keller PM, Shiver JW, Liang X, Joyce JG. Comparative immunogenicity evaluations of influenza A virus M2 peptide as recombinant virus like particle or conjugate vaccines in mice and monkeys. Vaccine. 2009; 27:1440-1447. [PubMed: 19146898] 29. De Filette M, Martens W, Smet A, Schotsaert M, Birkett A, Londono-Arcila P, Fiers W, Saelens X. Universal influenza A M2e-HBc vaccine protects against disease even in the presence of preexisting anti-HBc antibodies. Vaccine. 2008; 26:6503-6507. [PubMed: 18835315] 30. De Filette M, Min Jou W, Birkett A, Lyons K, Schultz B, Tonkyro A, Resch S, Fiers W. De Filette M, Ramne A, Birkett A, Lycke N, Lowenadler B, Min Jou W, Saelens X, Fiers W. Fiers W, De Filette M, El Bakkouri K, Schepens B, Roose K, Schotsaert M, Birkett A, Saelens X. Maurer P, Jennings GT, Willers J, Rohner F, Lindman Y, Roubicek K, Renner WA, Muller P, Bachmann MF. A therapeutic vaccine for nicotine dependence: preclinical efficacy, and Phase I safety and immunogenicity. Eur J Immunol. 2005; 35:2031-2040. [PubMed: 15971275] 36. Ambuhl PM, Tissot AC, Fulurija A, Maurer P, Nussberger J, Sabat R, Nief V, Schellekens C, Kuritsky JN, Osterholm MT, Korlath JA, White KE, Kaplan JE. A statewide assessment of the role of Norwalk virus in outbreaks of food-borne gastroenteritis. J Infect Dis. Bereszczak JZ, Barbu IM, Tan M, Xia M, Jiang X, van Duijn E, Heck AJ. Structure, stability and dynamics of norovirus P domain derived protein complexes studied by native mass spectrometry. J Tan M, Xia M, Huang P, Wang L, Zhong W, McNeal M, Wei C, Jiang X. Norovirus P Particle as a Platform for Antigen Presentation. Procedia in Vaccinology. 2011; 4:19-26. 41. Xia M, Tan M, Wei C, Zhong W, Wang L, McNeal M, Jiang X. A candidate dual vaccine against influenza and noroviruses. Vaccine. 2011; 29:7670-7677. [PubMed: 21839795] 42*. Weintraub ES, Baggs J, Duffy J, Vellozzi C, Belongia EA, Irving S, Klein NP, Glanz JM, Jacobsen SJ, Naleway A, et al. Risk of Intussusception after Monovalent Rotavirus Vaccination. N Engl J Med. 2014 [This new study indicated a risk of intussusception after rotavirus vaccination, suggestion a need of consideration of balancing between risks and health benefits of rotavirus vaccines.] 43. Glass RI, Parashar UD. Rotavirus Vaccines -Balancing Intussusception Risks and Health Benefits. N Engl J Med. 2014 44. Yih WK, Lieu TA, Kulldorff M, Martin D, McMahill-Walraven CN, Platt R, Selvam N, Selvan M, Lee GM, Nguyen M. Intussusception Risk after Rotavirus Vaccination in U.S. Infants. N Engl J Med. 2014 45. Chen XS, Casini G, Harrison SC, Garcea RL. Papillomavirus capsid protein expression in Escherichia coli: purification and assembly of HPV11 and HPV16 L1. J Mol Biol. 2001; 307:173-182. [PubMed: 11243812] 46. Nam HM, Chae KS, Song YJ, Lee NH, Lee JB, Park SY, Song CS, Seo KH, Kang SM, Kim MC, et al. Immune responses in mice vaccinated with virus-like particles composed of the GP5 and M proteins of porcine reproductive and respiratory syndrome virus. Arch Virol. 2013; 158:1275-1285. [PubMed: 23392631] 47. Martinez-Torrecuadrada JL, Saubi N, Pages-Mante A, Caston JR, Espuna E, Casal JI. Structure-Martinez-Torrecuadrada JL, Saubi N, Pages-Mante A, Caston JR, Espuna E, Casal JI. Structure-Jiang X, Matson DO, Ruiz-Palacios GM, Hu J, Treanor J, Pickering LK. Expression, selfassembly, and antigenicity of a snow mountain agent-like calicivirus capsid protein. Laurent S, Vautherot JF, Madelaine MF, Le Gall G, Rasschaert D. Recombinant rabbit hemorrhagic disease virus capsid protein expressed in baculovirus self-assembles into viruslike particles and induces protection. J Virol. 1994; 68:6794-6798. [PubMed: 8084017] 53. Wang L, Huang P, Fang H, Xia M, Zhong W, McNeal MM, Jiang X, Tan M. Mortola E, Roy P. Efficient assembly and release of SARS coronavirus-like particles by a heterologous expression system. FEBS Lett. 2004; 576:174-178. [PubMed: 15474033] 55. Bai B, Hu Q, Hu H, Zhou P, Shi Z, Meng J, Lu B, Huang Y, Mao P, Wang H. Virus-like particles Baumert TF, Ito S, Wong DT, Liang TJ. Hepatitis C virus structural proteins assemble into viruslike particles in insect cells. J Virol. 1998; 72:3827-3836. [PubMed: 9557666] 60. Jeong SH, Qiao M, Nascimbeni M, Hu Z, Rehermann B, Murthy K, Liang TJ. Immunization with hepatitis C virus-like particles induces humoral and cellular immune responses in nonhuman primates. J Virol. 2004; 78:6995-7003. [PubMed: 15194776] 61. Murata K, Lechmann M, Qiao M, Gunji T, Alter HJ, Liang TJ. Immunization with hepatitis C virus-like particles protects mice from recombinant hepatitis C virus-vaccinia infection. Proc Natl Nassal M, Skamel C, Kratz PA, Wallich R, Stehle T, Simon MM. A fusion product of the complete",
            "latex": null,
            "type": "table"
        },
        "TABREF1": {
            "text": "Curr Opin Virol. Author manuscript; available in PMC 2015 June 01. Ab, antibody; B. burgdorferi, Borrelia burgdorferi; BV, betanodavirus; BTV, bluetongue virus; CHIKV, chikungunya virus; CoV, coronavirus; CPV, conine parvovirus; CTL, cytotoxic-T-lymphocyte; CVA16, coxsackievirus A-16; CVB3, coxsackievirus B3; E. coli, Escherichia coli; EBOV, ebolavirus; EMCV, encephalomyocarditis virus; EV71, Enterovirus 71; EBV, epstein-barr virus; FHV, flock house virus; Flu virus, influenza virus; FMDV, foot-and-mouth disease virus; GPV, Goose parvovirus; HBV, hepatitis B virus; HCV, hepatitis C virus; HEV, hepatitis E virus; HIV, human immunodeficiency virus; HPV, human papillomavirus; IBDV, Infectious bursal disease virus; IBV, infectious bronchitis virus; NDV, Newcastle disease virus; NoV, norovirus; PCV, porcine circovirus; PPV, porcine parvovirus; PRRSV, porcine reproductive and respiratory syndrome virus; PV, parvovirus; PyV, polyomavirus; RV, rotavirus; RHDV, Rabbit haemorrhagic disease virus; RSV, respiratory syncytial virus; RVFV, Rift Valley fever virus; SARS, severe acute respiratory syndrome; SV40, simian vacuolating virus 40 or simian virus 40; VLP, virus-like particle.",
            "latex": null,
            "type": "table"
        },
        "TABREF2": {
            "text": "",
            "latex": null,
            "type": "table"
        },
        "TABREF3": {
            "text": "Some vaccine candidates that are in preclinical development CPMV Curr Opin Virol. Author manuscript; available in PMC 2015 June 01. PyV VLP Pre-S1 epitope of HBV VLP N-termini of NP of PUUV VLP CTL epitope of mucin 1 VLP PSA antigens of D2F2 tumors Baculovirus Ab, T cell Protection against tumor growth [101] VLP H190 epitope of influenza virus Ab, antibody; B. burgdorferi, Borrelia burgdorferi; CFP-10, antigen of culture filtrate protein 10; CPMV, cowpea mosaic virus; CSP, circumsporozoite protein; CTL, cytotoxic-T-lymphocyte; DENV-1/2, dengue virus type-1/2; EDIII, envelope domain III; EV71, Enterovirus 71; FHV, Flock House virus; Flu virus, influenza virus; FMDV, foot-and-mouth disease virus; FnBP, fibronectin-binding protein; GAS, Group A streptococcus; GP, glycoprotein; HA/NA, hemagglutinin/neuraminidase; HAV, hepatitis A virus; HBV, hepatitis B virus; HCV, hepatitis C virus; HEV, hepatitis E virus; HMPV, human metapneumovirus; HVR1, hypervariable region 1; IBDV, infectious bursal disease virus; IBV, infectious bronchitis virus; INF, interferon; LCMV, Lymphocytic choriomeningitis virus; M2e, ectodomain of influenza A virus M2 protein; MEV, Mink enteritis virus; MTB, mycobacterium tuberculosis; NDV, Newcastle disease virus; NP, nucleocapsid protein; NoV, norovirus; P. falciparum, Plasmodium falciparum; P. aeruginosa, Pseudomonas aeruginosa; PyV, polyomavirus; PUUV, Puumala hantavirus; RV, rotavirus; RHDV, rabbit haemorrhagic disease virus; RSV, respiratory syncytial virus; SV40, simian vacuolating virus 40 or simian virus 40; T. aureus, Taphylococcus aureus; VLP, virus-like particle; WNV, West Nile virus. Opin Virol. Author manuscript; available in PMC 2015 June 01.",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": [
        {
            "text": "The laboratories of the authors are supported by the National Institute of Health (R01AI089634, P01 HD13021 to X.J. and R21AI092434 to M.T), Department of Agricultures (NIFA, AFRI to X. J.) of the United States of America, and an institutional Clinical and Translational Science Award (NIH/NCRR 8UL1TR000077-04 to M.T.)",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Acknowledgments"
        }
    ]
}